nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
|
Leuzy, Antoine |
|
|
48 |
7 |
p. 2295-2305 |
artikel |
2 |
A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images
|
Bucci, Marco |
|
|
48 |
7 |
p. 2183-2199 |
artikel |
3 |
Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
|
Chiotis, Konstantinos |
|
|
48 |
7 |
p. 2086-2096 |
artikel |
4 |
Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework
|
Wolters, E. E. |
|
|
48 |
7 |
p. 2097-2109 |
artikel |
5 |
Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
|
Bischof, Gérard N |
|
|
48 |
7 |
p. 2110-2120 |
artikel |
6 |
Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts
|
Provost, Karine |
|
|
48 |
7 |
p. 2259-2271 |
artikel |
7 |
Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison
|
Altomare, Daniele |
|
|
48 |
7 |
p. 2200-2211 |
artikel |
8 |
Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
|
Salvadó, Gemma |
|
|
48 |
7 |
p. 2212-2224 |
artikel |
9 |
Indication of retrograde tau spreading along Braak stages and functional connectivity pathways
|
Seemiller, Joseph |
|
|
48 |
7 |
p. 2272-2282 |
artikel |
10 |
Molecular imaging and fluid biomarkers of Alzheimer’s disease neuropathology: an opportunity for integrated diagnostics
|
Garibotto, Valentina |
|
|
48 |
7 |
p. 2067-2069 |
artikel |
11 |
Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives
|
Cotta Ramusino, Matteo |
|
|
48 |
7 |
p. 2157-2168 |
artikel |
12 |
Reduced [18F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter
|
Moscoso, Alexis |
|
|
48 |
7 |
p. 2283-2294 |
artikel |
13 |
Relationship between amyloid and tau levels and its impact on tau spreading
|
Doré, Vincent |
|
|
48 |
7 |
p. 2225-2232 |
artikel |
14 |
Tau PET imaging with 18F-PI-2620 in aging and neurodegenerative diseases
|
Mormino, Elizabeth C. |
|
|
48 |
7 |
p. 2233-2244 |
artikel |
15 |
The impact of demographic, clinical, genetic, and imaging variables on tau PET status
|
Ossenkoppele, Rik |
|
|
48 |
7 |
p. 2245-2258 |
artikel |
16 |
The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update
|
Boccardi, Marina |
|
|
48 |
7 |
p. 2070-2085 |
artikel |
17 |
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers
|
Ashton, N. J. |
|
|
48 |
7 |
p. 2140-2156 |
artikel |
18 |
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
|
Leuzy, A. |
|
|
48 |
7 |
p. 2121-2139 |
artikel |
19 |
Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent
|
Collij, Lyduine E. |
|
|
48 |
7 |
p. 2169-2182 |
artikel |